IRIS
CANONICA, Giorgio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 12.702
EU - Europa 3.298
AF - Africa 607
AS - Asia 605
SA - Sud America 16
OC - Oceania 15
Continente sconosciuto - Info sul continente non disponibili 13
Totale 17.256
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 12.530
FI - Finlandia 964
IE - Irlanda 831
NG - Nigeria 597
FR - Francia 403
DE - Germania 316
NL - Olanda 255
CN - Cina 215
GB - Regno Unito 187
TR - Turchia 175
CA - Canada 169
SE - Svezia 98
IT - Italia 94
IL - Israele 79
RU - Federazione Russa 47
IN - India 34
BE - Belgio 19
ES - Italia 14
IR - Iran 14
JP - Giappone 13
AU - Australia 11
HK - Hong Kong 11
UA - Ucraina 11
AT - Austria 10
ID - Indonesia 9
RO - Romania 9
A2 - ???statistics.table.value.countryCode.A2??? 8
BR - Brasile 7
CL - Cile 7
SA - Arabia Saudita 7
SG - Singapore 7
GR - Grecia 6
KR - Corea 6
PL - Polonia 6
CZ - Repubblica Ceca 5
EG - Egitto 5
GE - Georgia 5
IQ - Iraq 5
NO - Norvegia 5
CH - Svizzera 4
DK - Danimarca 4
EU - Europa 4
MN - Mongolia 4
NZ - Nuova Zelanda 4
TH - Thailandia 4
BD - Bangladesh 3
MD - Moldavia 3
PH - Filippine 3
PK - Pakistan 3
PT - Portogallo 3
TW - Taiwan 3
AE - Emirati Arabi Uniti 2
AR - Argentina 2
BG - Bulgaria 2
LB - Libano 2
MX - Messico 2
ZA - Sudafrica 2
AL - Albania 1
AP - ???statistics.table.value.countryCode.AP??? 1
BF - Burkina Faso 1
HU - Ungheria 1
JO - Giordania 1
MA - Marocco 1
PA - Panama 1
UG - Uganda 1
Totale 17.256
Salva come PNG Salva come JPEG
Città #
Wilmington 4.545
San Mateo 1.701
Ann Arbor 1.033
Helsinki 963
Leawood 870
Dublin 829
Lawrence 774
Princeton 774
Benin City 597
Fairfield 578
Woodbridge 513
Chandler 488
Paris 387
Amsterdam 236
Shanghai 184
Kocaeli 169
London 164
Toronto 160
New York 106
Ashburn 101
Norwalk 96
Boardman 84
Monmouth Junction 43
Falkenstein 32
Phoenix 28
Des Moines 24
Moscow 24
Seattle 24
Brussels 19
Los Angeles 19
Milan 19
Redmond 18
Redwood City 18
San Diego 18
Beijing 16
Cambridge 14
Clearwater 14
Andover 13
Abbiategrasso 12
Falls Church 10
Frankfurt am Main 9
Hanover 9
Houston 8
Jakarta 8
Meppel 8
Augusta 7
Pune 7
Kemerovo 6
Istanbul 5
Prague 5
Bangkok 4
Duncan 4
Fremont 4
Hong Kong 4
Krakow 4
Lutz 4
Mumbai 4
Newark 4
Pescia 4
Santa Clara 4
Winnipeg 4
Castel Maggiore 3
Chisinau 3
Dornbirn 3
Gothenburg 3
Las Vegas 3
Leipzig 3
Madrid 3
Novokuznetsk 3
Philadelphia 3
Porto 3
Rio De Janeiro 3
Riyadh 3
Rome 3
Sacramento 3
Saint Louis 3
Saint Paul 3
Scranton 3
Tokyo 3
Ulaanbaatar 3
Alexandria 2
Apo 2
Athens 2
Auckland 2
Austin 2
Baabda 2
Bengaluru 2
Berlin 2
Burewala 2
Cebu City 2
Changsha 2
Cocoa Beach 2
Dronten 2
Guangzhou 2
Gunzenhausen 2
Hyderabad 2
Imperia 2
Jacksonville 2
Jeddah 2
King Of Prussia 2
Totale 15.930
Salva come PNG Salva come JPEG
Nome #
100 years of immunotherapy: the Monaco charter. under the high patronage of His Serene Highness Prince Albert II of Monaco 90
A critical appraisal on AIT in childhood asthma. 76
An academic allergy unit during COVID-19 pandemic in Italy. 66
Allergic sensitization to common pets (cats/dogs) according to different possible modalities of exposure: an Italian Multicenter Study. 66
Shadow cost of oral corticosteroids-related adverse events: A pharmacoeconomic evaluation applied to real-life data from the Severe Asthma Network in Italy (SANI) registry. 60
A Charter to Improve Patient Care in Severe Asthma 59
Evolving phenotypes to endotypes: is precision medicine achievable in asthma? 56
Pharmacokinetics and pharmacodynamics of monoclonal antibodies for asthma treatment 55
30 Years Of Sublingual Immunotherapy 54
Effects on symptoms and quality of life of hypertonic saline nasal spray added to antihistamine in persistent allergic rhinitis--a randomized controlled study 53
Immunological mechanisms underlying chronic rhinosinusitis with nasal polyps 52
Microarray Immunodiagnostics for Aeroallergens 52
Very rapid improvement of extended nitric oxide parameters, associated with clinical and functional betterment, in patients with chronic rhinosinusitis with nasal polyps (CRSwNP) treated with Dupilumab 51
Comparison of intranasal azelastine to intranasal fluticasone propionate for symptom control in moderate-to-severe seasonal allergic rhinitis 51
60Co therapy as an "allergic breakthrough" in a case of food allergy 51
Strategies to reduce corticosteroid-related adverse events in asthma 50
Real-life studies of biologics used in asthma patients: key differences and similarities to trials. 49
Aligning the Good Practice MASK With the Objectives of the European Innovation Partnership on Active and Healthy Ageing 49
Turkish Version of the Chronic Urticaria Quality of Life Questionnaire: Cultural Adaptation, Assessment of Reliability and Validity 49
2019 ARIA Care pathways for allergen immunotherapy 49
A 4-year trial of tiotropium in chronic obstructive pulmonary disease 47
A multi-allergen ELISA screening method. Comparison with Pharmacia CAP system and Phazet skin prick test 47
A double-blind, placebo-controlled study on the diagnostic accuracy of an electrodermal test in allergic subjects 46
A survey of the burden of allergic rhinitis in Europe 46
Treatable traits in chronic rhinosinusitis with nasal polyps 46
Predictors of response to omalizumab and relapse in chronic spontaneous urticaria: a study of 470 patients 45
The Severe Asthma Network in Italy: Findings and Perspectives. 44
Appropriateness in allergic respiratory diseases health care in Italy: definitions and organizational aspects 44
A common language to assess allergic rhinitis control: results from a survey conducted during EAACI 2013 Congress 44
Pharmacoeconomic evaluation of oral corticosteroid adverse events in patients with severe asthma 44
Omalizumab for Idiopathic Nonhistaminergic Angioedema: Evidence for Efficacy in 2 Patients. 43
Inhaled corticosteroids safety and adverse effects in patients with asthma 43
Asthma: personalized and precision medicine 43
A multicentric study on sensitivity and specificity of a new in vitro test for measurement of IgE antibodies 43
A model of allergen-driven human airway contraction:beta2 pathway dysfunction without cytokine involvement 43
Choosing wisely in Allergology: a Slow Medicine approach to the discipline promoted by the Italian Society of Allergy, Asthma and Clinical Immunology (SIAAIC) 43
Current insights in allergen immunotherapy. 42
A Review of the Evidence from Comparative Studies of Levocetirizine and Desloratadine for the Symptoms of Allergic Rhinitis 42
A new tool to assess and monitor the burden of chronic cough on quality of life: Chronic Cough Impact Questionnaire 42
A new protocol for specific oral tolerance induction in children with IgE-mediated cow's milk allergy 42
A review of the use of fluticasone furoate since its launch 41
360 degree perspective on allergic rhinitis management in Italy: A survey of GPs, pharmacists and patients 41
Adherence to treatment in allergic rhinitis using mobile technology. The MASK Study 41
A new tool to evaluate the impact of chronic urticaria on quality of life: chronic urticaria quality of life questionnaire (CU-QoL) 41
EUFOREA consensus on biologics for CRSwNP with or without asthma. 40
Diagnosis and management of moderate to severe adult atopic dermatitis: a Consensus by the Italian Society of Dermatology and Venereology (SIDeMaST), the Italian Association of Hospital Dermatologists (ADOI), the Italian Society of Allergy, Asthma and Clinical Immunology (SIAAIC), and the Italian Society of Allergological, Environmental and Occupational Dermatology (SIDAPA) 40
A three-year double-blind placebo-controlled study with specific oral immunotherapy to Dermatophagoides: evidence of safety and efficacy in paediatric patients 40
A role for the intranasal formulation of azelastine hydrochloride/fluticasone propionate in the treatment of allergic rhinitis 40
EAACI guidelines on allergen immunotherapy: Executive statement 39
GA(2)LEN skin test study I: GA(2)LEN harmonization of skin prick testing: novel sensitization patterns for inhalant allergens in Europe 39
Escaping the trap of allergic rhinitis. 37
Development and implementation of guidelines in allergic rhinitis – an ARIA-GA2LEN paper 37
New drugs in early-stage clinical trials for allergic rhinitis 37
EAACI/GA(2)LEN/EDF/WAO guideline: management of urticaria 37
Ketotifen treatment of adverse reactions to foods: clinical and immunological effects 37
[GA(2)LEN (Global Allergy and Asthma European Network): European network of excellence for asthma and allergic diseases] 37
La diagnostica delle malattie autoimmuni 37
Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials 37
Characteristics and treatment regimens across ERS SHARP severe asthma registries. 36
GA2LEN (Global Allergy and Asthma European Network) addresses the allergy and asthma 'epidemic' 36
The EAACI/GA(2) LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update 36
GA(2)LEN skin test study II: clinical relevance of inhalant allergen sensitizations in Europe 36
Year in review: Allergen immunotherapy 36
The EAACI/GA²LEN/EDF/WAO Guideline for the Definition, Classification, Diagnosis and Management of Urticaria. The 2017 Revision and Update 35
Choosing wisely: practical considerations on treatment efficacy and safety of asthma in the elderly. 34
T cell activation surface markers and autologous mixed lymphocyte reaction do not differ in true and pseudo food allergy 34
Suppressor activity of T cells bearing Fc-receptors for IgG on lymphoid colony formation 34
T cell activation through different membrane structures (T3/Ti, T11, T44) and frequency analysis of proliferating and interleukin-2 producer T lymphocyte precursors in aged individuals 34
Performance evaluation of ImmunoCAP® ISAC 112: a multi-site study 34
[ICAM-1 and allergic inflammation] 34
Clinical outcomes related to molecular allergy diagnosis. 33
Wellbeing, illness perception and coping strategies in Italian celiac patients 33
Erratum to: Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5)(Clin Transl Allergy (2016) 6 (29) DOI: 10.1186/s13601-016-0116-9) 33
[Our experience in the treatment of bronchial asthma and asthmatic bronchitis with salbutamol] 33
The North-Western Italian experience with anti IL-5 therapy amd comparison with regulatory trials. 32
Subpopulation of human T lymphocytes, functional characteristics 32
EAACI: A European Declaration on Immunotherapy. Designing the future of allergen specific immunotherapy 32
International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis 32
Abnormalities of circulating T cell subsets in atopy: influence of specific immunotherapy 32
T-lymphocyte activation and allergy 32
Pilot study of mobile phone technology in allergic rhinitis in European countries: The MASK-rhinitis study 32
The adhesion molecules of allergic inflammation: recent insights into their functional roles 31
EAACI/GA(2)LEN/EDF/WAO guideline: definition, classification and diagnosis of urticaria 31
Serious Asthma Events with Budesonide plus Formoterol vs. Budesonide Alone 31
Evaluation of the nocebo effect during oral challenge in patients with adverse drug reactions 31
Cutting Edge: Biomarkers for Chronic Spontaneous Urticaria. 30
Efficacy of desloratadine in intermittent allergic rhinitis: a GA(2)LEN study 30
Allergic Rhinitis and its Impact on Asthma (ARIA): achievements in 10 years and future needs 30
Imbalance of circulating T lymphocytes subsets in allergic ophtalmorhinitis 30
Atopic asthma: evaluation of T-cell activation by means of 4F2 monoclonal antibody 30
Comparison of the colony forming capacities of human T lymphocyte subpopulations 30
Imbalances of T cell subpopulations in patients with atopic diseases and effect of specific immunotherapy 30
Circulating T cell subsets in euthyroid Graves' disease 30
EAACI/GA(2)LEN/EDF/WAO - Guideline for the Definition, Classification, Diagnosis and Management of Urticaria - Consensus, German Translation Guideline of the European Academy of Allergology and Clinical Immunology (EAACI), the Global Allergy and Asthma European Network (GA(2)LEN), the European Dermatology Forum (EDF) and the World Allergy Organization (WAO) 30
What do we need to learn to optimize the SLIT alternative? 29
Autoimmune thyroid disease: purification and phenotypic analysis of intrathyroid T cells 29
EAACI/GA2LEN/EDF guideline: definition, classification and diagnosis of urticaria 29
Continuing Medical Education:an international reality 29
Autologous mixed lymphocyte reaction in Graves' disease: relationship to clinical status 29
EAACI/GA2LEN/EDF guideline: management of urticaria 29
Totale 4.058
Salva come PNG Salva come JPEG
Categoria #
all - tutte 174.152
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 174.152
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020768 0 0 0 0 0 0 0 0 0 0 0 768
2020/20218.215 11 32 11 12 18 2.504 1.317 572 2.073 696 14 955
2021/20223.082 117 7 51 784 15 17 131 613 304 296 683 64
2022/20234.274 1.623 85 827 139 101 86 19 93 282 777 220 22
2023/20241.856 169 388 773 31 32 141 119 117 53 33 0 0
Totale 18.195